The Weed Blog has reported news from CannaKids and Saving Sophie in the past, and we are hugely supportive of their efforts. We feel that organizations such as these will be a big piece of what helps end cannabis prohibition in the United States, and hopefully world wide, ultimately. Here is the latest from them!
OXNARD, Calif., May 31, 2017 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that the CURE and the CannaKids partnership has entered into a strategic research collaboration with Technion Research and Development Foundation Ltd., wholly owned subsidiary of the Technion-Israel Institute of Technology, in order to research how different cannabinoid compounds within cannabis strains can be used to treat various subtypes of cancer.
Researchers from CURE’s Pharmaceutical Cannabinoid Division and Technion’s Laboratory of Cancer Biology and Cannabinoid Research will work together to research and identify how varying cannabinoid compounds within cannabis strains can affect various cancer subtypes. The results of the…